Changing regulatory environments, new customer demands around the globe, challenges around product security and increasingly complex products are driving healthcare executives to make strategic supply chain investments, according to findings from the sixth annual UPS “Pain in the (Supply) Chain” healthcare survey, conducted by TNS. New technology investments and go-to-market models are top of mind as healthcare executives drive business and logistics transformations to meet evolving industry needs.
Over the next five years, 84 percent of global healthcare executives surveyed will invest in new technologies, 78 percent will enter new global markets and 70 percent will implement new distribution channels such as going direct to providers, retailers and even end-patients. In addition, 59 percent will increase reliance on third-party logistics partners. Together, these strategies indicate a move toward transformation in the healthcare supply chain.
Technology investments, in particular, signal growing concerns over product protection, which includes the security of high-value shipments and product spoilage, with large jumps in the number of executives planning to invest over the next three to five years in systems that support e-pedigree/ serialization, temperature-sensitive and product security solutions.
For the first time since the survey’s inception in 2008, product security surpassed cost management as the second supply chain concern with 53 percent of executives citing it as a top issue. Executives face challenges in product security with the top concern being increasing counterfeit sophistication at 48 percent, followed by poor supply chain visibility, with 40 percent citing it as an issue.Despite investment plans, concerns over the global economy and healthcare business landscape continue. Globally, 50 percent are still feeling the impacts of the economic downturn, and 60 percent in the U.S. are reporting continued impacts. Executives in Asia express the most optimism on the economy with only 31 percent reporting they are still feeling the effects.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts